Vedanta Biosciences
PrivateLast Round
Early Funding
Aug 6, 2026
Total Funding Raised
$317.5M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Vedanta Biosciences is a biotechnology company that develops microbiome-based oral therapies for the treatment of immune-mediated and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vedanta Biosciences Comparables
Compare Vedanta Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Seres Therapeutics Inc | 81% | |
| MarvelBiome Inc. | 81% | |
| EnteroBiotix | 80% | |
Vedanta Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 6, 2026 | ||||
| Grant | Apr 30, 2024 | ||||
| VC Round | Apr 25, 2023 | ||||
| Series D | Jul 21, 2021 | ||||
| Grant | Sep 30, 2020 | ||||
Grant | Dec 5, 2019 |
Vedanta Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Investment | Series C Extension, Series C |
| AMR Action Fund | VC Round, Early Funding |
| SymBiosis Capital Management | Series D, Series C Extension, Series C |
| Invesco Ltd. | Series C, Series B |
| Administration for Strategic Preparedness and Response | Grant |
| Salica Investments | VC Round |
| Korea Investment Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 6, 2026
$40M round led by BNP Paribas Asset Management and AMR Action Fund.
- Apr 1, 2026
Lead asset VE303 enters Phase 3 trial for C. difficile infection.
Vedanta Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vedanta Biosciences's valuation, stock price, and market status.